3333 East Camelback Road, Suite 270
3 articles with Genomica Corporation
GENOMICA, a wholly owned company of PharmaMar Group, is developing a kit to reliably detect and identify the new virus known as "Wuhan pneumonia".
GENOMICA (PharmaMar Group) & Huasin Science completes the first CLART® diagnostic equipment for the China market
GENOMICA, the molecular diagnostics company belonging to the PharmaMar Group (MSE:PHM), begins to materialize its first contract in China with the medical equipment company, HuaSin Science, to lead the global challenge of the early diagnosis of cervical cancer in China.
Collaboration Between Scienion AG And Genomica Corporation Results In A Novel Multiplex Based Detection Kit For The Identification And Specific Differentiation Of 18 Microorganism Causing Sexual Transmitted Infections (STIs)